| 8(1) |
G4 |
None Cited |
Assay |
2%; reprinted 8(5), 9(6), 10(3), 10(5), 11(4) |
| 8(1) |
S1AB |
None Cited |
Assay |
NULL |
| 13(6) |
G19 |
OV-225 |
Assay |
0.25-µm capillary column. |
| 17(3) |
G19 |
None Cited |
Concomitant components |
See Assay |
| 8(1) |
G4 |
None Cited |
Free . . . . . . . . . . . |
steroids; see Assay |
| 13(6) |
G19 |
OV-225 |
Free . . . . . . . . . . . |
steroids; see Assay |
| 8(1) |
G4 |
None Cited |
Identity |
See Assay |
| 13(6) |
G19 |
OV-225 |
Identity |
See Assay; reprinted 14(5) |
| 8(1) |
S1AB |
None Cited |
Limit of . . . . . . . . . |
17a-dihydroequilin; see Assay |
| 8(1) |
G4 |
None Cited |
Limit of . . . . . . . . . |
17a-dihydroequilin; see Assay |
| 17(3) |
G19 |
None Cited |
Limit of . . . . . . . . . |
17-beta-estradiol and delta-8,9-dehydroestrone; see Assay |
| 17(3) |
G43 |
None Cited |
Organic volat. impurities |
See Method V  467 |
| 17(3) |
G19 |
None Cited |
Signal impurities |
See Assay |